Ignite Creation Date:
2025-12-25 @ 12:46 AM
Ignite Modification Date:
2026-01-05 @ 6:18 PM
Study NCT ID:
NCT01242267
Status:
COMPLETED
Last Update Posted:
2023-01-03
First Post:
2010-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
Sponsor:
Hackensack Meridian Health
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PRO00001215
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |